Geron's Stem Cell Bust Leaves Investors Holding the Bag

by Web Master, Benzinga Editor
November 15, 2011 9:15 AM | 5 seconds read |
Wall Street not likely to fund new stem cell ventures in the wake of Geron's failure.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!